Hawk and harrier: phase 3, multicenter, randomizaed, double-masked trials of brolucizumab for neovascular age-related macular degeneration
The authors are commenting on the study entitled “Hawk and Harrier: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration” published by Dugel et al.